Literature DB >> 30047988

Treatment for Alcohol Use Disorder: Progress in Predicting Treatment Outcome and Validating Nonabstinent End Points.

Kasey G Creswell1, Tammy Chung2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30047988      PMCID: PMC6167145          DOI: 10.1111/acer.13846

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


× No keyword cloud information.
  50 in total

1.  Modeling the complexity of post-treatment drinking: it's a rocky road to relapse.

Authors:  Katie Witkiewitz; G Alan Marlatt
Journal:  Clin Psychol Rev       Date:  2007-01-18

2.  Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.

Authors:  Joseph P Schacht; Patrick K Randall; Patricia K Latham; Konstantin E Voronin; Sarah W Book; Hugh Myrick; Raymond F Anton
Journal:  Neuropsychopharmacology       Date:  2017-04-14       Impact factor: 7.853

3.  Multidimensional alcoholism typologies: could they guide clinical practice? Results from a 3-month prospective study.

Authors:  Samuel Pombo; Nuno Félix da Costa; Maria Luísa Figueira; Fátima Ismail; Otto Michael Lesch
Journal:  Int J Psychiatry Clin Pract       Date:  2015-03-12       Impact factor: 1.812

4.  Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study.

Authors:  Scott E Lukas; Steven B Lowen; Kimberly P Lindsey; Nina Conn; Wendy Tartarini; John Rodolico; Gopi Mallya; Christopher Palmer; David M Penetar
Journal:  Neuroimage       Date:  2013-04-06       Impact factor: 6.556

Review 5.  Diagnosis of chronic alcoholism--classificatory problems.

Authors:  O M Lesch; J Kefer; S Lentner; R Mader; B Marx; M Musalek; A Nimmerrichter; H Preinsberger; H Puchinger; A Rustembegovic
Journal:  Psychopathology       Date:  1990       Impact factor: 1.944

6.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

Review 7.  Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders.

Authors:  Claire E Wilcox; Jessica M Pommy; Bryon Adinoff
Journal:  Am J Psychiatry       Date:  2016-01-15       Impact factor: 18.112

Review 8.  Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.

Authors:  Laura E Kwako; Reza Momenan; Raye Z Litten; George F Koob; David Goldman
Journal:  Biol Psychiatry       Date:  2015-11-17       Impact factor: 13.382

Review 9.  Social cognition in alcoholism: a link to prefrontal cortex dysfunction?

Authors:  Jennifer Uekermann; Irene Daum
Journal:  Addiction       Date:  2008-05       Impact factor: 6.526

10.  An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Authors:  Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David Couper; Robert Swift; Helen Pettinati; David Goldman
Journal:  Arch Gen Psychiatry       Date:  2008-02
View more
  4 in total

1.  Drinking beyond the binge threshold in a clinical sample of adolescents.

Authors:  Kasey G Creswell; Tammy Chung; Carillon J Skrzynski; Rachel L Bachrach; Kristina M Jackson; Duncan B Clark; Christopher S Martin
Journal:  Addiction       Date:  2020-02-15       Impact factor: 6.526

Review 2.  Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder.

Authors:  Falk W Lohoff
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

3.  Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges.

Authors:  Rachel L Tomko; Kevin M Gray; Marilyn A Huestis; Lindsay M Squeglia; Nathaniel L Baker; Erin A McClure
Journal:  Curr Addict Rep       Date:  2019-11-19

4.  Contrastive Analysis of Neuropsychology and Personality Characteristics of Male Lacunar Infarction Patients with Hazardous Drinking and Non-Hazardous Drinking.

Authors:  Jia Yang; Zhandong Qiu; Yu Fang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-27       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.